Der Report
Tiefgehende Einblicke in Unternehmensfinanzierung, Wachstumsstrategien und Markterkenntnisse der innovativsten Unternehmen der Welt
15 Berichte und es werden mehr
Novartis Headquarters - Office Location & Address
Discover Novartis's headquarters at Lichtstrasse 35, Basel 4056. Pharmaceutical company. Learn about the office facilities and work environment.
Syngenta Headquarters - Office Location & Address
Discover Syngenta's headquarters at Schwarzwaldallee 215, Basel, 4058. Crop protection and seeds. Learn about the office facilities and work environment.
Roche Headquarters - Office Location & Address
Discover Roche's headquarters at Grenzacherstrasse 124, Basel 4070. Pharmaceutical and diagnostics company. Learn about the office facilities and work environment.
Panalpina Headquarters - Office Location & Address
Discover Panalpina's headquarters at Viaduktstrasse 42, Basel, 4002. Freight forwarding and logistics services. Learn about the office facilities and work environment.
Electra Therapeutics Raises $183 Million in Series C - October 22, 2024
Electra Therapeutics announced $183 Million in Series C funding at a Undisclosed valuation. Electra Therapeutics raised an oversubscribed $183 million Series C to advance clinical trials for novel immunology therapies targeting autoimmune and...
Roche Raises $280B in Public
Roche, a Pharmaceuticals company based in Grenzacherstrasse 124, Basel 4070, Switzerland, has raised $280B in Public at a $300B valuation led by Public.
Novartis Raises $220B in Public
Novartis, a Pharmaceuticals company based in Lichtstrasse 35, Basel 4056, Switzerland, has raised $220B in Public at a $240B valuation led by Public.
Syngenta Group Raises $1.5B in Series Unknown
Syngenta Group, a AgriTech company based in Rosentalstrasse 67, Basel 4002, Switzerland, has raised $1.5B in Series Unknown at a $40B valuation led by ChemChina, CNRC, Sinochem.
CRISPR Therapeutics Raises $337M in Follow-on Offering
CRISPR Therapeutics, a Biotech company based in Aeschenvorstadt 36, Basel 4051, Switzerland, has raised $337M in Follow-on Offering at a $8B valuation led by Versant Ventures, Bayer, Vertex Pharmaceuticals.
9 Berichte angezeigt • Seite 1 • Kategorie: all
Bleiben Sie dem Markt voraus
Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.